A Novel Combination Oral Agent to Treat Acne Vulgaris

• Status: Unknown status
• Trial end date: 2011-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to evaluate a novel, combination product for the treatment of acne vulgaris in females

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Nexgen Dermatologics, Inc.
• Treatments: Doxycycline; Equol

Criteria

Inclusion Criteria:

• Healthy females 13 years of age or older

• Non-pregnant, non-lactating females

• Signed written informed consent form

• Must be able to understand and be willing to follow all study instructions

• Have a clinical diagnosis of acne vulgaris

Exclusion Criteria:

• Female subjects who are pregnant or nursing

• Any concomitant dermatologic condition that may affect outcome measures

• Concurrent use of any other medication to treat acne vulgaris

• Have a history or clinical evidence of any other active acute or chronic medical disease or condition considered by the principal investigator as unsuitable for the study

• Are currently using any other investigational agent or device

• Have participated in any other clinical study within 90 days prior to enrollment

• Employees or family members of sponsor or research site